title: Cisplatin as an active treatment in zoledronate-refractory hypercalcemia.
authors: Department of Medical Genetics, National Taiwan University Hospital; Department of Medical Genetics; Department of Internal Medicine, China Medical University Hospital.
authors: P-H
authors: PH
authors: Lin
authors: Department of Internal Medicine, China Medical University Hospital.
authors: C-F
authors: CF
authors: Chiu
authors: Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan. Electronic address: yslu@ntu.edu.tw.
authors: Y-S
authors: YS
authors: Lu
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000150:complications / Q000188:drug therapy / Q000556:secondary; D001943:Breast Neoplasms / Q000473:pathology / Q000601:surgery; D018270:Carcinoma, Ductal, Breast / Q000150:complications / Q000188:drug therapy / Q000556:secondary / Q000601:surgery; D002945:Cisplatin / Q000627:therapeutic use*; D004164:Diphosphonates / Q000627:therapeutic use*; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy* / Q000209:etiology; D007093:Imidazoles / Q000627:therapeutic use*; D002955:Leucovorin / Q000008:administration & dosage; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D017211:Treatment Failure; D014747:Vinblastine / Q000008:administration & dosage / Q000031:analogs & derivatives; D000077235:Vinorelbine; D000077211:Zoledronic Acid
chemical_list: D000970:Antineoplastic Agents; D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D014747:Vinblastine; D000077211:Zoledronic Acid; D002945:Cisplatin; D002955:Leucovorin; D000077235:Vinorelbine; D005472:Fluorouracil